LIMITED-STAGE SMALL CELL LUNG CANCER
Clinical trials for LIMITED-STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED-STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED-STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shield cancer patients from chemo side effects
Disease control Not yet recruitingThis study tests a drug called trilaciclib in people with limited-stage small cell lung cancer. The goal is to see if it can protect the bone marrow from damage caused by chemotherapy. About 120 participants will receive either trilaciclib or a placebo during their cancer treatme…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for lung cancer patients: drug combo targets tough tumors
Disease control Not yet recruitingThis study tests a new drug called adebrelimab, given together with standard chemotherapy and radiation, for people with limited-stage small-cell lung cancer. The goal is to see if this combination helps control the disease longer and is safe. About 30 adults aged 18-75 will take…
Matched conditions: LIMITED-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 22, 2026 13:50 UTC